An; Haoyun

Patent Applications and Registrations

Patent applications and USPTO patent grants for An; Haoyun.The latest application filed is for "urea peptoid boric acid compound, pharmaceutical composition thereof, preparation method therefor, and uses thereof".

Company Profile

1.22.19

An; Haoyun - Beijing CN
An; Haoyun - Zhengzhou N/A CN
An; Haoyun - Zhengzhou City CN
An; Haoyun - Carlsbad CA US
An; Haoyun - Encinitas CA
An; Haoyun - Provo UT

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Urea peptoid boric acid compound, pharmaceutical composition thereof, preparation method therefor, and uses thereof Grant 10,494,384 - Li , et al. De	2019-12-03
Urea Peptoid Boric Acid Compound, Pharmaceutical Composition Thereof, Preparation Method Therefor, And Uses Thereof App 20180298036 - Li; Runtao ; et al.	2018-10-18
Pyrimidine nucleoside derivatives, synthesis methods and uses thereof for preparing anti-tumor and anti-virus medicaments Grant 9,422,321 - Chang , et al. August 23, 2	2016-08-23
Pyrimidine Nucleoside Derivatives, Synthesis Methods And Uses Thereof For Preparing Anti-tumor And Anti-virus Medicaments App 20130303747 - Chang; Junbiao ; et al.	2013-11-14
Synthesis and use of 2'-substituted-N6-modified nucleosides Grant 8,575,331 - An , et al. November 5, 2	2013-11-05
Substituted organosulfur compounds and methods of using thereof Grant 8,334,316 - Xu , et al. December 18, 2	2012-12-18
Heterocyclic compounds and uses as anticancer agents Grant 8,252,822 - An , et al. August 28, 2	2012-08-28
Synthesis And Use Of 2'-substituted-n6-modified Nucleosides App 20110196144 - An; Haoyun ; et al.	2011-08-11
Synthetic process for anticancer drug fluorapacin and trisulfide derivatives Grant 7,851,657 - An , et al. December 14, 2	2010-12-14
Synthesis and use of 2'-substituted-N.sup.6 -modified nucleosides Grant 7,799,908 - An , et al. September 21, 2	2010-09-21
Synthetic Process For Anticancer Drug Fluorapacin And Trisulfide Derivateves App 20100191016 - An; Haoyun ; et al.	2010-07-29
Substituted organosulfur compounds and methods of using thereof Grant 7,622,507 - Xu , et al. November 24, 2	2009-11-24
Substituted Organosulfur Compounds And Methods Of Using Thereof App 20090192146 - XU; Xiao ; et al.	2009-07-30
Heterocyclic Compounds And Uses As Anticancer Agents App 20090048271 - An; Haoyun ; et al.	2009-02-19
Synthesis for hydroxyalkylated heterocyclic bases Grant 7,371,857 - Ramasamy , et al. May 13, 2	2008-05-13
2-beta -modified-6-substituted adenosine analogs and their use as antiviral agents Grant 7,217,815 - An , et al. May 15, 2	2007-05-15
Quinoxaline derivatives having antiviral activity Grant 7,189,724 - An , et al. March 13, 2	2007-03-13
Synthesis and use of 2'-substituted-n6-modified nucleosides App 20060135465 - An; Haoyun ; et al.	2006-06-22
Synthesis for hydroxyalkylated heterocyclic bases App 20060135768 - Ramasamy; Kanda ; et al.	2006-06-22
Dinucleotide inhibitors of de novo RNA polymerases for treatment or prevention of viral infections App 20060074035 - Hong; Zhi ; et al.	2006-04-06
Tetrahydrocannabinoid antigens and method of use App 20060051824 - An; Haoyun ; et al.	2006-03-09
Heterocyclic compounds and uses thereof Grant 6,989,451 - Zhang , et al. January 24, 2	2006-01-24
C3' -methylene hydrogen phosphonate oligomers and related compounds Grant 6,974,865 - Cook , et al. December 13, 2	2005-12-13
Substituted organosulfur compounds and methods of using thereof App 20050261321 - Xu, Xiao ; et al.	2005-11-24
Inhibitors for de novo-RNA polymerases and methods of identifying targets for same Grant 6,906,190 - Yao , et al. June 14, 2	2005-06-14
Quinoxaline derivatives having antiviral activity App 20050026923 - An, Haoyun ; et al.	2005-02-03
Nucleosides having bicyclic sugar moiety Grant 6,833,361 - Hong , et al. December 21, 2	2004-12-21
Complex chemical libraries Grant 6,800,444 - Cook , et al. October 5, 2	2004-10-05
Di-ribonucleotides as specific viral RNA-polymerase inhibitors for the treatment or prevention of viral infections App 20040158054 - Wu, Jim Zhen ; et al.	2004-08-12
Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase App 20040110717 - Carroll, Steven S. ; et al.	2004-06-10
Heterocyclic compounds and uses thereof App 20040039037 - Zhang, Weijian ; et al.	2004-02-26
C3'-methylene hydrogen phosphonate oligomers and related compounds Grant 6,639,061 - Cook , et al. October 28, 2	2003-10-28
Inhibitors for de novo-RNA polymerases and methods of identifying targets for same App 20030187000 - Yao, Nanhua ; et al.	2003-10-02
C3' -methylene hydrogen phosphonate oligomers and related compounds App 20030139586 - Cook, Phillip Dan ; et al.	2003-07-24
Novel nucleosides having bicyclic sugar moiety App 20030028013 - Wang, Guangyi ; et al.	2003-02-06
Compounds having a plurality of nitrogenous substitutents Grant 6,329,523 - Cook , et al. December 11, 2	2001-12-11
Nitrogenous macrocyclic compounds Grant 6,107,482 - Cook , et al. August 22, 2	2000-08-22
Processes for removing, separating and concentrating lead, thallium, alkali metals, alkaline earth metals from concentrated matrices using macrocyclic polyether cryptand ligands bonded to inorganic supports Grant 5,393,892 - Krakowiak , et al. February 28, 1	1995-02-28

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.